Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain

Pain Physician

Volumn 14, Issue 4, 2011, Pages 343-351

  Grider, Jay S ^a   Harned, Michael E ^a   Etscheidt, Mark A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Chronic noncancer pain; Intrathecal drug delivery; Intrathecal opioids; Oral opioid therapy

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; COURSE EVALUATION; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERANCE; FUNCTIONAL ASSESSMENT; HUMAN; INTRACTABLE PAIN; LOW DRUG DOSE; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PATIENT SELECTION; RETROSPECTIVE STUDY; REVIEW; TREATMENT DURATION; VISUAL ANALOG SCALE;

ANALGESICS, OPIOID; CHRONIC PAIN; CLINICAL TRIALS AS TOPIC; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MORPHINE; PAIN MEASUREMENT; PATIENT SELECTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960879259     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Wallace M and Yaksh TL. Long-term spinal analgesic delivery: A review of the preclinical and clinical literature. Reg Anesth Pain Med 2000; 25:117-157.
2. Deer TR, Smith HS, Cousins M, Doleys DM, Levey RM, Rathmel JP, Staats PS, Wallace M, Webster LR. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Phys 2010; 13:E175-E213.
3. Deer TR, Krames ES, Hassenbusch SG, Burton A, Caraway D, DuPen S, Eisenach J, Erdeck M, Grigsby E, Kim P, Levy R, McDowell G, Mekhail N, Panchal S, Prager J, Rauch R, Saulino M, SItzman T, Staats P, Stanton-Hicks M, Stearns L, Willis KD, Witt WO, Follett K, Huntoon M, Liem L, Rathmell J, Wallace M, Buchser E, Cousins M, Ver Donck A. ARTICLE TITLE? Neuromodulation 2007; 10:300-328.
4. Grider JS, Harned ME, Sloan PA. Patient selection and trialing techniques utilizing low-dose intrathecal morphine for chronic nonmalignant pain: a report of two cases. J Opioid Manag 2010; 6:371-376.
5. Witt WO, Richardson WB. Intrathecal low-dose morphine; case study 3 and 4. Synchromed 2 programmable infusion system. Product Bulletin. Minneapolis, MN: Medtronic Neuromodulation; 2010.
6. American Society of Anesthesiologists Task Force on Neuraxial Opioids, Horlocker TT, Burton AW, Connis RT, Hughes SC, Nickinovich DG, Palmer CM, Pollock JE, Rathmell JP, Rosenquist RW, Swisher JL, Wu CL. Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration. Anesthesiology 2009; 110:218-230.
7. Grider JS, Brown RE, Colclough GE. Perioperative management of patients with an intrathecal drug delivery system for chronic pain. Anesth Analg 2008; 107:1393-1396.
8. Williamson A. Pain: A review of three commonly used pain rating scales. Issues Clin Nur 2005; 14:798-804.
9. Smith HS, Deer TR, Staats PS, Singh V, Sehgal N, Cordner H. Intrathecal drug delivery. Pain Physician 2008; 11:S89-S104.
10. Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. Intrathecal therapy for cancer and non-cancer pain. Pain Physician. 2011; 14:219-248.
11. Deer TR, Smith HS, Cousins M, Doleys DM, Levy RM, Rathmell JP, Staats PS, Wallace M, Webster LR. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician 2010; 13:E175-E213.
12. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999; 44:289-300.
13. Angel IF, Gould HJ, Carey ME. Intrathecal morphine pump as treatment option in chronic pain of nonmalignant origin. Surg Neurol 1998; 49:92-99.
14. Hassenbusch SJ, Stanton-Hicks M, Covington EC, Walsh JG, Guthery DS. Longterm intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995; 10:527-543.
15. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: Long-term benefits and efficacy. Surg Neurol 2001; 55:79-86.
16. Thimineur MA, Kravitz K, Vodapollay MS. Intrathecal opioid treatment for chronic non-malignant pain: A 3-year prospective study. Pain 2004; 109:242-249.
17. Deer T, Chapple I, Classen A, Javery K, Stoker V, Tonder L, Burchiel K. Intrathecal drug delivery for treatment of chronic low back pain: report from the national outcomes registry for low back pain. Pain Med 2004; 5:6-13.
18. Trescot A, Glaser SE, Hansen H, Benyamin R, Patel S, Manchikanti L. Effectiveness of opioids in the treatment of non-cancer pain. Pain Physician 2008; 11:S181-S200.
19. Pud D, Cohen D, Lowental E, Eisenburg E. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug Alc Dep 2006; 82:218-223.
20. Compton P, Charuvastra C, Kintaudi K, Ling W. Pain responses in methadonemaintained opioid abusers. J Pain Symptom Manage 2000; 20:237-245.
21. Hay JL, White JM, Somogyi AA, Bochner F, Rounsefell B, Demple T. Clinical evidence for opioid-induced hyperalgeisa. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 2003; 10:4.
22. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain 2008; 24:479-496.
23. Grider JS, Ackerman WE. Opioid-induced hyperalgesia and tolerance: Understanding opioid side effects. Expert Rev Clin Pharmacol 2008; 1:291-297.
24. Coffey RJ, Owens ML, Broste SK, Dubois MY, Ferrante MF, Schultz DM, Stearns LJ, Turner MS. Mortality associated with implantation and management of intrathecal drug infusion systems to treat chronic non-cancer pain. Anesthesiology 2009; 11:881-891.
25. Bedder MD, Burchiel K, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Mange 1991; 6:368-373.
26. De Lissovoy G, Brown RE, Halpern M, Hassenbusch SJ, Ross E. Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. Clin Ther 1997; 19:96-112.
27. Kumar K, Hunter G, Demeria DD. Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: A cost-effectiveness analysis. J Neurosurg 2002; 97:803-810.